BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35050434)

  • 1. Transanal versus laparoscopic total mesorectal excision: a comparative study of long-term oncological outcomes.
    Ourô S; Ferreira M; Roquete P; Maio R
    Tech Coloproctol; 2022 Apr; 26(4):279-290. PubMed ID: 35050434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.
    Seow W; Dudi-Venkata NN; Bedrikovetski S; Kroon HM; Sammour T
    Tech Coloproctol; 2023 May; 27(5):345-360. PubMed ID: 36508067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.
    Munini M; Popeskou SG; Galetti K; Roesel R; Mongelli F; Christoforidis D
    Int J Colorectal Dis; 2021 Oct; 36(10):2271-2279. PubMed ID: 34467413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.
    Veltcamp Helbach M; Koedam TWA; Knol JJ; Diederik A; Spaargaren GJ; Bonjer HJ; Tuynman JB; Sietses C
    Surg Endosc; 2019 Jan; 33(1):94-102. PubMed ID: 29967990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.
    Xu W; Xu Z; Cheng H; Ying J; Cheng F; Xu W; Cao J; Luo J
    Eur J Surg Oncol; 2016 Dec; 42(12):1841-1850. PubMed ID: 27697315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 11. Anastomotic leakage and chronic presacral sinus after transanal total mesorectal excision (taTME) for rectal cancer: A comparative study to laparoscopic TME.
    Jang HB; Kang SB; Lee H; Choi BJ; Lee SC
    Asian J Surg; 2022 Nov; 45(11):2197-2202. PubMed ID: 34801358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis.
    de Lacy FB; Roodbeen SX; Ríos J; van Laarhoven J; Otero-Piñeiro A; Bravo R; Visser T; van Poppel R; Valverde S; Hompes R; Sietses C; Castells A; Bemelman WA; Tanis PJ; Lacy AM
    BMC Cancer; 2020 Jul; 20(1):677. PubMed ID: 32689968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal NOTES total mesorectal excision (TME) in patients with rectal cancer: Is anatomy better preserved?
    Chouillard E; Regnier A; Vitte RL; Bonnet BV; Greco V; Chahine E; Daher R; Biagini J
    Tech Coloproctol; 2016 Aug; 20(8):537-44. PubMed ID: 26993638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transanal Total Mesorectal Excision Considering the Embryology Along the Fascia in Rectal Cancer Patients.
    Yoshimitsu K; Mori S; Tanabe K; Wada M; Hamada Y; Yasudome R; Kurahara H; Arigami T; Sasaki K; Koriyama C; Higashi M; Nakajo A; Ohtsuka T
    Anticancer Res; 2023 Aug; 43(8):3597-3605. PubMed ID: 37500175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution.
    Kagami S; Funahashi K; Koda T; Ushigome T; Kaneko T; Suzuki T; Miura Y; Nagashima Y; Yoshida K; Kurihara A
    World J Surg Oncol; 2022 Nov; 20(1):363. PubMed ID: 36376924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis.
    Yi Chi Z; Gang O; Xiao Li F; Ya L; Zhijun Z; Yong Gang D; Dan R; Xin L; Yang L; Peng Z; Yi L; Dong L; De Chun Z
    Medicine (Baltimore); 2024 Jan; 103(4):e36859. PubMed ID: 38277570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transanal Total Mesorectal Excision (TaTME) versus Laparoscopic Total Mesorectal Excision for Lower Rectal Cancer: A Propensity Score-Matched Analysis.
    Lin YC; Kuo YT; You JF; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Yeh CY; Hsieh PS; Liao CK
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Serra-Aracil X; Zarate A; Bargalló J; Gonzalez A; Serracant A; Roura J; Delgado S; Mora-López L;
    Br J Surg; 2023 Jan; 110(2):150-158. PubMed ID: 36224406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transanal total mesorectal excision-a critical appraisal].
    Holmer C; Benz S; Fichtner-Feigl S; Jehle EC; Kienle P; Post S; Schiedeck T; Weitz J; Kreis ME
    Chirurg; 2019 Jun; 90(6):478-486. PubMed ID: 30911795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.